There is no fixed price for the shares. It is a fixed exchange of shares of BYLK for Nicolet. I am going to wait and see how the new business does as well as see what the dividend is going to be. This is still likely a buyout target in a few years. The market cap will roughly double with the merger but that is still a very small bank. Without a buyout, one of the positives is still that you are in a very stable financial market with an economy that does not tend to get over extended.
With a micro cap it can be difficult to figure out why a stock moves in either direction. If you google the company for news, there was a director who bought shares as well as North Star adding shares. It could be that the Brazil market is finally going to happen. I think PMD has decent, not great prospects going forward based on the hair testing business. Despite being the first to market with hair testing, PMD is not the only company in the space. Given its narrow scope, the company has a limited upside. My other rational for owning the company is that it would appear to eventually be a good take over target. The small size of PMD would fit nicely into the drug testing business of another lab and the administration/marketing costs could be spread out more efficiently. If you look at the age of the directors and founder, it would make sense that something like this would happen in the next few years.
This has to be one of the lamest posts ever. Do you (sloven, most, seri, pahel etc.) have this as a cut and paste with a fill in number or do you waste the time to type it out every time the stock is off its high of the day? By the way, with the after hours it was up 90 cents for the day.
I think there are two reasons. The first it that overall it was a bad day for the market. This is obviously not the only reason. When you look at adjusted EPS of $0.32 vs $0.08 GAAP you get a clue. You might say adjusted EPS of $0.32, that's fantastic until you realize that the other $0.24 went to stock based compensation. That is $2.4 million in stock based compensation. When the company is run this much for the benefit of the management and so little for the benefit of other shareholders, it is no wonder that the price has gone down more than 99.5% from its peak. It is also a likely reason that institutions have stayed away.